RESPIRATORY FUNCTION IN PATIENTS WITH RHEUMATIC HEART DISEASE COMPLICATED WITH PULMONARY HYPERTENSION

RESPIRATORY FUNCTION IN PATIENTS WITH RHEUMATIC HEART DISEASE COMPLICATED WITH PULMONARY HYPERTENSION

Show other versions (1)

<p>Aim. To evaluate the changes of respiratory function in patients with rheumatic heart disease (RHD) complicated with pulmonary hypertension (PH) by the spirographic investigation. Materials and methods. Patients (n=56; 4 men and 52 women; aged 63,25±7,93) with rheumatic combined mitral and...

Full description

Bibliographic Details
Main Authors:	N. A. Shostak, A. A. Klimenko, I. A. Novikov
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-01-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	ревматическая болезнь сердца легочная гипертензия спирография легочная рестрикция
Online Access:	http://www.rpcardio.ru/jour/article/view/680

Similar Items

Vasoreactivity testing in pulmonary hypertension associated with congenital heart disease
by: A. A. Shmalts, et al.
Published: (2022-10-01)

CLINICAL FEATURES OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL SYSTEMIC-TO-PULMONARYSHUNTS
by: S. Ye. Gratsianskaya, et al.
Published: (2017-12-01)

COMPARATIVE CLINICAL CHARACTERISTICS OF PATIENTS WITH VARIOUS FORMS OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL HEART DISEASE, ACCORDING TO THE CLINICAL CLASSIFICATION
by: S. E. Gratsianskaya, et al.
Published: (2019-12-01)

Diagnosis of pulmonary hypertension associated with congenital heart disease. Part 1. Definition, classification and initial examination of patients
by: S. V. Gorbachevsky, et al.
Published: (2021-12-01)

Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension associated with congenital heart defects in adults (2021)
by: I. E. Chazova, et al.
Published: (2022-05-01)

Diagnosis of pulmonary hypertension associated with congenital heart disease. Part 2. Echocardiography
by: I. Yu. Baryshnikova, et al.
Published: (2022-01-01)

CASE REPORT ON THE SUCCESSFUL USE OF A NEW SELECTIVE PROSTACYCLIN IP RECEPTOR AGONIST, SELEXIPAG, IN A PATIENT WITH IDIOPATHIC PULMONARY HYPERTENSION
by: Z. S. Valieva, et al.
Published: (2019-12-01)

CLINICAL CASE OF REPLACEMENT OF ENDOTHELIN RECEPTOR ANTAGONIST (BOSENTAN) BY SOLUBLE GUANYLATE CYCLASE STIMULATOR (RIOCIGUAT) IN THE PATIENT WITH PULMONARY ARTERIAL HYPERTENSION
by: E. A. Devetyarova, et al.
Published: (2018-06-01)

Calculation of hemodynamics by the Fick method in pulmonary hypertension associated with congenital heart defects
by: A. A. Shmalts, et al.
Published: (2022-05-01)

Pharmacological test with sildenafil at pulmonary hypertension assessing in children with congenital heart diseases
by: O. S. Yanulevich, et al.
Published: (2010-10-01)

CARDIOPULMONARY EXCERSISE TESTING IN RISK STRATIFICATION IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
by: I. N. Taran, et al.
Published: (2017-12-01)

NUCLEAR IMAGING IN PULMONARY HYPERTENSION
by: V. B. Sergienko, et al.
Published: (2017-03-01)

Prostacyclin receptor agonist selexipag in a patient with high-risk idiopathic pulmonary arterial hypertension: a case report
by: E. A. Rezukhina, et al.
Published: (2021-09-01)

ORAL ANTICOAGULANTS IN PATIENTS WITH DIFFERENT FORMS OF PULMONARY ARTERIAL HYPERTENSION, ASPECTS OF THE PROBLEM
by: S. Ye. Gratsianskaya, et al.
Published: (2017-12-01)

CLINICAL CASE: CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION IN A CHILD
by: D. J. Sadykova, et al.
Published: (2017-03-01)

The incidence of acute rheumatic fever and chronic rheumatic heart disease in the Russian population (2011–2012)
by: Rimma Mikhailovna Balabanova
Published: (2014-03-01)

About choosing a vasodilator for vasoreactivity tests in heart transplant candidates
by: А. Е. Баутин, et al.
Published: (2015-10-01)

THE ROLE OF RADIATION DIAGNOSTIC TECHNIQUES IN THE DIAGNOSIS OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
by: E. A. Mershina, et al.
Published: (2016-07-01)

EXPERIENCE OF IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION PATIENTS MANAGEMENT IN URAL FEDERAL DISTRICT: FEATURES OFOUTPATIENT-HOSPITAL INTERACTIONS
by: S. V. Shalaev, et al.
Published: (2019-03-01)

OPPORTUNITIES FOR OPTIMIZATION OF DRUG THERAPY BY ENDOTHELIN RECEPTOR ANTAGONISTS FOR THE PATIENT WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION AND ATRIAL SEPTOSTOMY
by: V. V. Gramovich, et al.
Published: (2018-12-01)

THE EFFICACY OF SILDENAFIL THERAPY IN PATIENTS WITH PULMONARY HYPERTENSION OF DIFFERENT ETIOLOGY: INFLUENCE ON THE CLINICAL, FUNCTIONAL, HEMODYNAMIC STATUS, STRUCTURE AND FUNCTION OF THE RIGHT AND LEFT HEART, RIGHT VENTRICULAR-ARTERIAL COUPLING
by: T. V. Martynyuk, et al.
Published: (2017-03-01)

Pulmonary hypertension syndrome in dilation cardiomyopathy patients: sildenafil application to common treatment of chronic heart failure
by: T. A. Abdullaev, et al.
Published: (2016-02-01)

Chronic thromboembolic pulmonary hypertension: approaches to diagnosis and treatment
by: N. A. Shostak, et al.
Published: (2013-12-01)

Drug-induced pulmonary artery hypertension
by: O. D. Ostroumova, et al.
Published: (2022-05-01)

Retrospective analysis of the occurrence of secondary pulmonary hypertension in patients with viral pneumonia based on ultrasound examination of the heart in patients with viral pneumonia in the context of the COVID-19 pandemic
by: E. Yu. Titova, et al.
Published: (2021-10-01)

The Impact of Pulmonary Hypertension on Functional and Morphological Parameters of Heart Function in COVID-19
by: D. S. Shilin, et al.
Published: (2022-02-01)

A clinical case of radiofrequency pulmonary artery denervation for treatment of a patient with residual chronic thromboembolic pulmonary hypertension
by: D. A. Feshchenko, et al.
Published: (2019-12-01)

EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (2020)
by: I. E. Chazova, et al.
Published: (2021-03-01)

PULMONAR.Y ARTERIAL HYPERTENSION ASSOCIATED WITH A SYSTEMIC SCLEROSIS: REVIEW OF LITERATURE
by: N. N. Yudkina, et al.
Published: (2015-12-01)

REMODELING OF THE RIGHT HEART AND THE LEVEL OF BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: A COMPARATIVE CROSS-SECTIONAL OBSERVATIONAL STUDY
by: A. A. Klimenko, et al.
Published: (2015-09-01)

THE COMPLEXITY OF DIAGNOSING IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION
by: D. I. Sadykova, et al.
Published: (2018-11-01)

THE ROLE OF RIOCIGUAT IN THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONNECTIVE TISSUE DISEASE
by: O. Ya. Vasiltseva, et al.
Published: (2019-12-01)

Heart rate variability in patients with chronic rheumatic heart disease
by: V. S. Petrov
Published: (2019-11-01)

Neonatal screening for life-threatening conditions persistent – pulmonary hypertension in newborns and critical congenital heart disease – by the method of pulse oximetry
by: D. I. Sadykova, et al.
Published: (2017-11-01)

LEFT MAIN CORONARY ARTERY COMPRESSION SYNDROME IN PATIENT WITH PULMONARY ARTERIAL HYPERTENSION. FIRST CLINICAL EXPERIENCE
by: A. N. Bykov, et al.
Published: (2018-12-01)

Corrected orthogonal vectorcardiography in pulmonary hypertension diagnostics
by: E. S. Yurasova, et al.
Published: (2005-12-01)

COVID-19 pandemic challenges: on the way to overcome obstacles in realization of PAH-specific therapy treatment goals
by: E. A. Rezukhina, et al.
Published: (2021-11-01)

Formation of the pulmonary hypertension in patients with a liver cirrhosis
by: T. P. Kalachyova, et al.
Published: (2009-08-01)

COMPARISON OF THE PREVALENCE AND DYNAMICS OF ANXIETY, DEPRESSION AND QUALITY OF LIFE IN PATIENTS WITH CHRONIC RHEUMATIC HEART DISEASE
by: V. S. Petrov
Published: (2019-05-01)

CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION AND PROBLEMS OF RARE AND INTERDISCIPLINARY DISEASE
by: N. A. Shostak, et al.
Published: (2015-09-01)